Search

Your search keyword '"Wei, Jinhuan"' showing total 183 results

Search Constraints

Start Over You searched for: Author "Wei, Jinhuan" Remove constraint Author: "Wei, Jinhuan"
183 results on '"Wei, Jinhuan"'

Search Results

2. Neonatal lactic acidosis and/or thrombocytopenia caused by multi-oil fat emulsion injection: two cases report and literature review

3. Exercise Reverses Immune-Related Genes in the Hippocampus of Multiple Sclerosis Patients

7. Three children of patent foramen ovale with headache and ( or ) dizziness as chief complaints

9. Integrated network pharmacology and GC–MS‐based metabolomics to investigate the chemical profile and efficacy of Anemarrhenae Rhizoma and its processed products.

10. Supplementary Data 3 from PABPC1L Induces IDO1 to Promote Tryptophan Metabolism and Immune Suppression in Renal Cell Carcinoma

11. Supplementary Data 1 from PABPC1L Induces IDO1 to Promote Tryptophan Metabolism and Immune Suppression in Renal Cell Carcinoma

12. Table S2 from PABPC1L Induces IDO1 to Promote Tryptophan Metabolism and Immune Suppression in Renal Cell Carcinoma

13. Supplementary Data 2 from PABPC1L Induces IDO1 to Promote Tryptophan Metabolism and Immune Suppression in Renal Cell Carcinoma

14. Data from PABPC1L Induces IDO1 to Promote Tryptophan Metabolism and Immune Suppression in Renal Cell Carcinoma

15. Supplementary Data from PABPC1L Induces IDO1 to Promote Tryptophan Metabolism and Immune Suppression in Renal Cell Carcinoma

16. Exploring the oncogenic potential of circSOD2 in clear cell renal cell carcinoma: a novel positive feedback loop

18. PABPC1L induces IDO1 to promote tryptophan metabolism and immune suppression in renal cell carcinoma

22. Urethral cavernous hemangioma: a highly misdiagnosed disease (a case report of two patients and literature review)

24. Data from Extracellular Vesicle-Mediated Transfer of LncRNA IGFL2-AS1 Confers Sunitinib Resistance in Renal Cell Carcinoma

25. Supplementary Data from Extracellular Vesicle-Mediated Transfer of LncRNA IGFL2-AS1 Confers Sunitinib Resistance in Renal Cell Carcinoma

28. EHBP1L1 Drives Immune Evasion in Renal Cell Carcinoma through Binding and Stabilizing JAK1

29. Neoadjuvant and adjuvant chemotherapy share equivalent efficacy in improving overall survival and cancer-specific survival among muscle invasive bladder cancer patients who undergo radical cystectomy: a retrospective cohort study based on SEER database

32. Impact of Time-To-Surgery on the Prognosis of Patients with T1 Renal Cell Carcinoma: Implications for the COVID-19 Pandemic

34. Extracellular Vesicle-Mediated Transfer of LncRNA IGFL2-AS1 Confers Sunitinib Resistance in Renal Cell Carcinoma

40. M6A-Immune-Related LncRNA Prognostic Signature for Predicting Immune Landscape and Prognosis of Bladder Cancer

43. Urethral cavernous hemangioma: a highly misdiagnosed disease (a case report of two patients and literature review)

49. Identification of an Immune-Related Risk Signature Correlates With Immunophenotype and Predicts Anti-PD-L1 Efficacy of Urothelial Cancer

Catalog

Books, media, physical & digital resources